VR Pilot for Pancreatitis Pain

This study is testing if a home-based virtual reality (VR) program can help adults with chronic pancreatitis (CP) pain. CP is a long-lasting inflammation of the pancreas that causes severe pain. The study will compare two VR experiences: one called "Gut Directed VR" which uses a specific therapy, and another called "Sham Control VR" which uses distracting games. Researchers want to see if using VR at home is practical and if it helps with pain and daily life. You might be able to join if you are 18 to 75 years old, have a diagnosis of CP, and experience significant abdominal pain. The study plans to enroll 20 participants, but its current status is unclear.

Study design
This is an interventional study with 20 planned participants, comparing two types of virtual reality experiences.
What's involved
You will complete questionnaires and provide biometric data from a Fitbit. The study lasts for 8 weeks.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed until the end of the study, which is 8 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06362187

VR Pilot for Pancreatitis

Not Yet Recruiting
NAAges 18–75InterventionalTreatment
Cedars-Sinai Medical Center
~20 participants
Updated 2026-08-05 on ClinicalTrials.gov
What's tested:Gut Directed VRSham Control VR

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of home-based VR
Measured over End of study (8 Weeks)
Chronic Pancreatitis
Recurrent Pancreatitis
1 sites across 1 states
California1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of CP \[as determined by Cambridge 3-4 imaging classification (using CT, MRI, or MRCP) or a histologic diagnosis of CP\]
Clinically significant abdominal pain, measured using the standardized NIH PROMIS GI Pain Scale14 and defined as scoring at least 5 points above the nationally normed score (0.5 SD effect size), indicating equal or greater than the minimally clinically important difference (MCID) of abdominal pain
Are 18-75 years of age
Are able to read/write English. The study does not include non-English speakers as to current study material are only available in English.

Exclusion

Patients who are presenting with a condition that interferes with VR usage (e.g., seizures, facial injury precluding safe placement of headset, visual impairment)
Patients who have cognitive impairment that affects protocol participation
Patients who are recommended for long-term hospitalization
Patients who are estimated to live \<3 months from the time of enrollment
Patients who have been diagnosed with a pancreatic tumor
Patients who have been enrolled in an interventional/therapeutic drug trial for chronic or recurrent pancreatitis within the last 6 months
  • Feasibility of home-based VREnd of study (8 Weeks)

    The primary objective of this study is to determine the feasibility of a home-based, standardized, gut-directed, virtual reality cognitive behavioral therapy (VR CBT) on clinical and functional outcomes of patients with chronic pain from chronic pancreatitis (CP) based on subject's ability to adhere to and complete the study. Feasibility will be met if ≥75% of enrolled patients complete the 8-week study.